November 19, 2015
(Edited) Dr Reddy’s refutes allegations
Dr. Reddy’s Laboratories has issued a press release reacting to certain statements that appeared in the certain media on Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 18, 2015
Health Canada to review Janssen’s NDS for daratumumab for Multiple Myeloma
Health Canada has accepted for review Janssen’s new drug submission (NDS) for daratumumab for treatment of Multiple Myeloma.
November 18, 2015
UK cost watchdog turns down Amgen’s new cholesterol drug
Amgen’s new injectable cholesterol drug Repatha has been turned down for use on Britain’s state health service, underscoring a worldwide debate about the value of such pricey medicines.
November 18, 2015
World Antibiotic Awareness Week; help patients get smart about antibiotic use
US Food and Drug Administration (FDA) has issued a video in which it suggest to pharmacists how to encourage the appropriate use of antibiotics.
November 18, 2015
Advanced Oncotherapy disposes of its subsiadiary for £100K
Advanced Oncotherapy has disposed of its subsidiary, Oncotherapy Resources Ltd (ORL), for a total cash consideration of £100,000 to Xstrahl.…
November 18, 2015
FDA grants Breakthrough Therapy designation to Avelumab for treating Merkel cell carcinoma
The US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough…
November 18, 2015
Anavex prepares for regulatory filings based on FDA guidance
Anavex is moving forward with the development program for ANAVEX 2-73 for the treatment of Alzheimer’s disease in a…
November 18, 2015
AmerisourceBergen in managerial changes. Adoption of proxy access
Steven H. Collis, the President and Chief Executive Officer (CEO) of AmerisourceBergen Corporation will succeed Richard C. Gozon as Chairman of the Board
November 18, 2015
Vertex gets EU approval for expanded use of its cystic fibrosis drug Kalydeco
The European Commission has approved expansion of the indication for Vertex Pharmaceuticals’ Kalydeco, to include children ages 2-5 with cystic fibrosis…
November 18, 2015
Hikma’s Portugal facility in compliance with US FDA
Hikma’s Portuguese facility back into compliance with the US FDA.